spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Cambrex 

 HSMN NewsFeed - 6 Jan 2023
Aeglea BioTherapeutics Announces Update to Corporate Structure to Increase Operational Efficiency
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Nov 2020
Elevian Announces $15 Million Equity Financing
Biopharmaceuticals Regenerative Medicine Venture Capital
 HSMN NewsFeed - 20 Mar 2017
Piramal Pharma Solutions Names Stuart E. Needleman as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Mar 2014
Stem Cell Therapeutics Strengthens its Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 10 Jan 2011
Raptor Pharmaceutical Hires Patrick Reichenberger to Lead Commercial Development of DR Cysteamine for Nephropathic Cystinosis
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 May 2008
Cambrex Appoints Steven M. Klosk as President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Feb 2008
BioVascular, Inc. Expands Executive Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jan 2008
NPS Pharmaceuticals Announces Board Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Nov 2007
NPS Pharmaceuticals Announces Senior Management Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jul 2007
Ortec International: Dr. Costa Papastephanou Appointed CEO
Regenerative Medicine Wound Care Personnel
 HSMN NewsFeed - 16 May 2007
Tercica Announces New Manufacturing Agreement with Lonza
Biopharmaceuticals
 HSMN NewsFeed - 9 Feb 2007
Cambrex Announces New Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Oct 2006
Cambrex Announces Sale of Bioproducts and Biopharma Subsidiaries to Lonza for $460 Million In Cash
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 Sep 2006
FDA Issues Approvable Letter to Ortec for Use of Cryopreserved OrCel(R) in Epidermolysis Bullosa Patients' Hand Reconstructions and Donor Sites
Regenerative Medicine FDA
 HSMN NewsFeed - 17 Jul 2006
Cambrex and Ortec Submit to FDA a Humanitarian Device Exemption (HDE) for OrCel(R) to Treat Epidermolysis Bullosa Patients
Devices
Return to NewsFeed  

 Additional items found! 12

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 12 additional stories matching:
Cambrex
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.